Erratum to ‘Sheri A, Dowsett M, Predicting response to cytotoxic drugs – The endocrine part of the story. The Breast, 2011: 20; S28 – S30.’

Abstract

The publisher regrets that there were two errors in the article referenced above, which was published as part of the Proceedings of the 12th St Gallen Primary Therapy of Early Breast Cancer Conference.A set of references unrelated to the article appeared in the main body of the text, affecting the section entitled ‘Effects of chemotherapy on menstruation’.The Conflict of Interest statement was incorrect. The Conflict of Interest statement should have read as follows:Conflict of Interest StatementM. Dowsett: Speakers’ Bureau: AstraZeneca, Roche; Consultancy: AstraZeneca, Roche, GSK, Ipsen. A. Sheri has no conflict of interest to declare.The publisher would like to sincerely apologize to Dr Sheri and Dr Dowsett for these errors. The publisher regrets that there were two errors in the article referenced above, which was published as part of the Proceedings of the 12th St Gallen Primary Therapy of Early Breast Cancer Conference. A set of references unrelated to the article appeared in the main body of the text, affecting the section entitled ‘Effects of chemotherapy on menstruation’. The Conflict of Interest statement was incorrect. The Conflict of Interest statement should have read as follows: Conflict of Interest StatementM. Dowsett: Speakers’ Bureau: AstraZeneca, Roche; Consultancy: AstraZeneca, Roche, GSK, Ipsen. A. Sheri has no conflict of interest to declare.The publisher would like to sincerely apologize to Dr Sheri and Dr Dowsett for these errors. M. Dowsett: Speakers’ Bureau: AstraZeneca, Roche; Consultancy: AstraZeneca, Roche, GSK, Ipsen. A. Sheri has no conflict of interest to declare. The publisher would like to sincerely apologize to Dr Sheri and Dr Dowsett for these errors.